Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin for Idiopathic Infantile Hypercalcemia
NCT03301038Phase 2Recruiting
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jul 2018
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifampicin in Idiopathic infantile hypercalcemia (IIH), sponsored by Children's Hospital of Philadelphia. Started Jul 2018; status: recruiting.
02
Drugs
rifampicin
03
Conditions
Idiopathic infantile hypercalcemia (IIH)
Beyond the preview
Go deeper on NCT03301038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03301038.